Stay updated on Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial page.

Latest updates to the Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial page
- Check7 days agoChange DetectedRevision: v3.5.0 has been added and Revision: v3.4.3 has been removed.SummaryDifference0.1%

- Check14 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3; this is a metadata change and does not alter the study details.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check43 days agoChange DetectedRevision: v3.4.2 was added and the v3.4.1 notice was removed. This appears to be a site maintenance update that does not affect the clinical trial details on the page.SummaryDifference0.5%

- Check50 days agoChange DetectedSite-wide notices were added about government funding lapse and clinic operations, and the site revision was updated to v3.4.1 (removing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check57 days agoChange DetectedShow glossary option added and metadata labels updated to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', along with a new 'Revision: v3.4.0'. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

- Check71 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3, indicating a version update of the page. No study details or user-facing functionality are altered.SummaryDifference0.1%

Stay in the know with updates to Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial page.